BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15003721)

  • 1. 4. The natural products epothilones A and B as lead structures for anticancer drug discovery: chemistry, biology, and SAR studies.
    Altmann KH; Flörsheimer A; O'Reilly T; Wartmann M
    Prog Med Chem; 2004; 42():171-205. PubMed ID: 15003721
    [No Abstract]   [Full Text] [Related]  

  • 2. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
    Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
    Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemistry and biology of epothilones--the wheel keeps turning.
    Altmann KH; Pfeiffer B; Arseniyadis S; Pratt BA; Nicolaou KC
    ChemMedChem; 2007 Apr; 2(4):396-423. PubMed ID: 17340668
    [No Abstract]   [Full Text] [Related]  

  • 4. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.
    Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH
    Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The merger of natural product synthesis and medicinal chemistry: on the chemistry and chemical biology of epothilones.
    Altmann KH
    Org Biomol Chem; 2004 Aug; 2(15):2137-52. PubMed ID: 15280945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 12-aza-epothilones (azathilones)--"non-natural" natural products with potent anticancer activity.
    Feyen F; Gertsch J; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2006 Sep; 45(35):5880-5. PubMed ID: 16871640
    [No Abstract]   [Full Text] [Related]  

  • 7. Complex target-oriented total synthesis in the drug discovery process: the discovery of a highly promising family of second generation epothilones.
    Rivkin A; Yoshimura F; Gabarda AE; Chou TC; Dong H; Tong WP; Danishefsky SJ
    J Am Chem Soc; 2003 Mar; 125(10):2899-901. PubMed ID: 12617656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and total synthesis of a superior family of epothilone analogues, which eliminate xenograft tumors to a nonrelapsable state.
    Chou TC; Dong H; Rivkin A; Yoshimura F; Gabarda AE; Cho YS; Tong WP; Danishefsky SJ
    Angew Chem Int Ed Engl; 2003 Oct; 42(39):4762-7. PubMed ID: 14562342
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy.
    Kumar A; Heise H; Blommers MJ; Krastel P; Schmitt E; Petersen F; Jeganathan S; Mandelkow EM; Carlomagno T; Griesinger C; Baldus M
    Angew Chem Int Ed Engl; 2010 Oct; 49(41):7504-7. PubMed ID: 20809556
    [No Abstract]   [Full Text] [Related]  

  • 11. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2.
    Wang J; Zhang H; Ying L; Wang C; Jiang N; Zhou Y; Wang H; Bai H
    J Antibiot (Tokyo); 2009 Sep; 62(9):483-7. PubMed ID: 19575038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis & antitumor activity of epothilones B and D and their analogs.
    Cheng H; Huang G
    Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epothilones: From discovery to clinical trials.
    Forli S
    Curr Top Med Chem; 2014; 14(20):2312-21. PubMed ID: 25434353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaffolds for microtubule inhibition through extensive modification of the epothilone template.
    Cachoux F; Isarno T; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2005 Dec; 44(45):7469-73. PubMed ID: 16240301
    [No Abstract]   [Full Text] [Related]  

  • 15. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives.
    Altmann KH; Gaugaz FZ; Schiess R
    Mol Divers; 2011 May; 15(2):383-99. PubMed ID: 21197573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulin and microtubules as targets for anticancer drugs.
    Hadfield JA; Ducki S; Hirst N; McGown AT
    Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and conformational analysis of (E)-9,10-dehydroepothilone B: a suggestive link between the chemistry and biology of epothilones.
    Yoshimura F; Rivkin A; Gabarda AE; Chou TC; Dong H; Sukenick G; Morel FF; Taylor RE; Danishefsky SJ
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2518-21. PubMed ID: 12800175
    [No Abstract]   [Full Text] [Related]  

  • 18. SAR and pH stability of cyano-substituted epothilones.
    Regueiro-Ren A; Leavitt K; Kim SH; Höfle G; Kiffe M; Gougoutas JZ; DiMarco JD; Lee FY; Fairchild CR; Long BH; Vite GD
    Org Lett; 2002 Oct; 4(22):3815-8. PubMed ID: 12599466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epothilones: mechanism of action and biologic activity.
    Goodin S; Kane MP; Rubin EH
    J Clin Oncol; 2004 May; 22(10):2015-25. PubMed ID: 15143095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of epothilones.
    Kolman A
    Curr Opin Investig Drugs; 2005 Jun; 6(6):616-22. PubMed ID: 15988913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.